admedicum
admedicum Patient Driven Solutions is a Cologne-based, founder-led patient engagement consultancy serving pharmaceutical, biotech, and patient organizations across the drug development lifecycle, with offices in six European and US cities and 30+ enterprise clients.
- Company typePrivate
- Founded2015
- HeadquartersCologne, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
What admedicum does
admedicum Patient Driven Solutions is a Cologne-headquartered, founder-led patient engagement consultancy founded in 2015 by two patient advocates with pharmaceutical industry backgrounds (Philipp von Gallwitz and Dr. Andreas L.G. Reimann). The firm designs, enables, and executes patient-focused activities across the full drug development lifecycle, with service lines spanning pre-clinical development, clinical development, HEOR and market access, commercialization, patient engagement and advocacy, and embedded in-house capacity building. Underlying technology is a Patient Co-Creation Framework that combines digital tools with human interaction; specific products include the patient2care knowledge platform (co-developed with the German Society for Muscular Diseases) and patient2site, a clinical trial recruitment technology.
admedicum serves pharmaceutical and biotechnology companies developing drugs and therapies, patient advocacy organizations seeking HTA and regulatory capacity, and healthcare payers and HTA bodies needing patient experience data. A stated client base of 30+ pharma and biotech companies includes Takeda, BioNTech, Merck, Bayer, UCB, Alexion, Sanofi, Biogen, MSD, and Novo Nordisk. The firm operates from offices in Cologne, Washington DC, Barcelona, Amsterdam, London, and Paris, with an extended partner network covering North America, the Middle East, Japan, and Australia.
The business model is professional services: project-based, quote-based consulting engagements sold primarily through direct enterprise outreach, supplemented by thought-leadership content (blog, podcast, webinars, peer-reviewed publications) and ecosystem roles such as the Secretariat of the SMA Newborn Screening Alliance and the Alliance for Pulmonary Hypertension. The legal entity is admedicum GmbH & Co KG, a German limited partnership, with no disclosed external institutional funding. Recognitions include the EURORDIS 2022 Patient Engagement Award and Global Health & Pharma's 2022 Best Patient Engagement & Access Expert designation.
admedicum firmographics
Firmographics- Name
- admedicum
- Legal name
- admedicum GmbH & Co KG
- Website
- https://admedicum.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- admedicum Patient Driven Solutions is a Cologne-based, founder-led patient engagement consultancy serving pharmaceutical, biotech, and patient organizations across the drug development lifecycle, with offices in six European and US cities and 30+ enterprise clients.
- Ownership category
- akta.pro rank
admedicum industry classification
Industry- Product category
- Patient Engagement Consulting
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Misc Health & Allied Services, Nec (8090), Services-Management Services (8741)
- akta.pro primary industry
- Clinical Trial Patient Recruitment & Retention (HLAGACAD)
Keywords
Where admedicum is headquartered
LocationHeadquarters
- HQ city
- Cologne
- HQ country
- Germany
- HQ region
- Europe
Offices6 records
Markets served
admedicum business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Consulting Services: Professional consulting services for patient engagement, patient advocacy, and patient access throughout the drug development lifecycle from pre-clinical to commercialization
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
admedicum product offering
Product offeringCore offering
admedicum is a patient engagement consultancy that designs, enables, and executes patient-focused activities for pharmaceutical, biotech, and patient-organization clients. It sells project-based consulting services spanning the full drug development lifecycle—from pre-clinical de-risking and clinical trial design to HEOR/market access, commercialization, and patient advocacy capacity building—using a Patient Co-Creation Framework and co-created digital platforms (patient2care, patient2site).
Product overview
admedicum is a patient engagement consultancy offering a unified suite of services spanning the entire drug development lifecycle: Pre-Clinical Development, Clinical Development, HEOR & Market Access, Commercialization, Patient Engagement & Advocacy, and Building In-House Capacity. The company also provides specific digital products including patient2care (a patient knowledge platform) and patient2site (clinical trial recruitment technology), along with HTA training programs for patient organizations. Their approach centers on co-creation with patient communities to generate patient experience data that informs regulatory, clinical, and access decisions.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- European patient survey contributed to EMA's decision to maintain orphan-drug-status of Mexiletine for NDM in November 2018
- +2 more outcomes
Companies that use admedicum
Customer profileNamed customers11 records
Segments3 records
Ideal customer profiles3 records
admedicum technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
admedicum partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- Global GenescoreStrategic collaboration to advance patient-driven research in rare diseases. The partnership aims to leverage Global Genes' research-grade data platform combined with admedicum's human-led patient engagement expertise to support disease understanding, outcome-measure refinement, and patient-centered evidence generation.
- MPS España (MPS Spain)coreStrategic partnership with patient association MPS España to improve the lives of people living with MPS (Mucopolysaccharidosis). Collaboration on capacity building and patient advocacy initiatives.
- Justin Stindt ConsultingminorStrategic partnership combining expertise to create value for both patients and industry in patient engagement projects. Companies have already successfully merged expertise in a number of projects.
- AparitominorCo-organised roundtable discussion on decentralized trials and collection of routine practice data for drug benefit assessment with ten sector participants.
- SMA EuropecoreAdmedicum serves as Secretariat for the European Alliance for Spinal Muscular Atrophy Newborn Screening (SMA NBS Alliance), founded in 2020 by SMA Europe and diverse stakeholders. Supports the white paper launch and ongoing alliance activities.
- Alliance for Pulmonary HypertensioncoreAdmedicum serves as Secretariat for the Alliance for Pulmonary Hypertension, supporting World Pulmonary Hypertension Day and organizational activities including communications, hosting, and moderating live events.
- Lymphoma CoalitionminorSupport for Lymphoma Coalition and its CAR-T project. Call for participation in patient engagement initiative.
- Deutsche Leberhilfe e.V.corePartnership supporting the 'Hepatitis-free Cologne' (Hepatitis-freies Köln) project led by Deutsche Leberhilfe e.V. (German Liver Aid) to diagnose hepatitis infections early and provide faster access to specialist treatment.
- German Society for Muscular Diseases (DGM)coreJoint development of patient2care, a knowledge platform developed through co-creation with and for patients with rare or complex diseases to help them navigate the healthcare system.
- LouLou FoundationminorCollaboration on CDKL5 Research & Family conference, with Philipp instrumental in shaping the agenda.
- Cure Myotonic Dystrophy UK CharityminorFounding Trustees Emma-Jayne and Peter Ashley collaborated on patient experience data for Myotonic Dystrophy research.
Scale indicators3 records
Recent moves8 records
Expansion highlights5 records
admedicum competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
admedicum social profiles
Digital presenceadmedicum financial estimates
Financial estimateRevenue estimate
Valuation estimate
admedicum leadership team
Management profileNumber of profiles
Profiles2 records
admedicum subsidiaries and ownership
Company hierarchySubsidiaries1 record
admedicum funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
admedicum M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about admedicum
What does admedicum do?
admedicum is a patient engagement consultancy that designs, enables, and executes patient-focused activities for pharmaceutical, biotech, and patient-organization clients. It sells project-based consulting services spanning the full drug development lifecycle—from pre-clinical de-risking and clinical trial design to HEOR/market access, commercialization, and patient advocacy capacity building—using a Patient Co-Creation Framework and co-created digital platforms (patient2care, patient2site).
Is admedicum a public or private company?
admedicum is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was admedicum founded?
admedicum was founded in 2015. It employs 11 to 50 people.
Where is admedicum based?
admedicum is headquartered in Cologne, Germany, in the Europe region.
How does admedicum make money?
One revenue line is on record: consulting Services.
Does admedicum have an API?
No public API is recorded for admedicum.
What industry is admedicum in?
admedicum's product category is Patient Engagement Consulting. Its primary akta.pro industry code is HLAGACAD, Clinical Trial Patient Recruitment & Retention. Its NAICS code is 5417 and its SIC code is 8090.